Three water soluble carboxy nitroxide antioxidants, CTMIO (5-carboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl, 1), CTEMPO (4-carboxy-2,2,6,6tetramethylpiperidin-1-yloxyl, 2) and CPROXYL (3-carboxy-2,2,5,5tetramethylpyrrolidin-1-yloxyl, 3) show significant impact on the post irradiation survival rates of Ataxia Telangiectasia (A-T) cells compared to normal cells; an assay which represents a model for understanding the impact of ROS damage on the A-T phenotype. The effect of these antioxidants is much more significant than for vitamin E or Trolox (a water-soluble vitamin E analogue), studied using the same cell survival model.
INTRODUCTION
Ataxia Telangiectasia (A-T) is an autosomal recessive, genetic childhood disease characterised by a pleiotropic phenotype which includes progressive cerebellar degeneration, immune dysfunction and genome instability [1, 2] . Patients with this disorder are strongly pre-disposed towards cancer, being highly susceptible to ionising radiation and radiomimetic chemicals. Early characteristics of A-T are cerebellar ataxia (lack of muscle control) and telangiectases (dilated blood vessels). All children with A-T experience a steady degeneration, or lack of development, of their motor skills and balance systems. More than half the children with A-T do not reach their teens and survival to the twenties is rare. A-T affects up to 1:100,000 live births and there is currently no treatment for the disease.
First described as a disease entity in 1957, the physiological and molecular basis of A-T remained unclear until the gene responsible was identified [3] and named Ataxia Telangiecstasia Mutated (ATM). The protein expressed by the ATM gene plays a key role in cellular responses to DNA damage and in the activation of cell cycle check points [4] . Recently, evidence has emerged that A-T cells exist under a constant state of oxidative stress with high levels of reactive oxygen species (ROS), which in turn may contribute to many of the degenerative processes observed in the disease [5, 6] . In this context it has been suggested that the neuronal defects in A-T may arise as a consequence of oxidative stress for which there is some evidence in the cerebellum of Atm deficient mice [7] [8] [9] [10] . With evidence of both reduced antioxidant capacity and the presence of high levels of oxidative stress in A-T cells, treatment of A-T patients with antioxidants should be of benefit. However, although the use of natural antioxidants, such as vitamin E (alpha-tocopherol) and vitamin C (ascorbic acid), has been proposed as a potential treatment, there has been little evidence to support their efficacy [11] , possibly because the bio-control mechanisms regulating these natural endogenous substances remain in place. Studies using alpha-lipoic acid [6] have shown decreased protein markers for oxidative stress in A-T cells, however complications with toxicity at the doses required to generate an effect has limited this approach. 
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One class of powerful antioxidants, the nitroxides, has not previously been investigated in this context. Nitroxides are stable free radicals able to scavenge radicals and act as radical chain terminators [12] . Recently it has become clear that, through one electron redox cycles which allow the reversible formation of the oxammonium cation or the hydroxylamine, nitroxides can act catalytically as superoxide dismutase mimics [13] . Equally, they may circumvent Fenton derived radical pathways by oxidising the metals involved. Nitroxides have a long history as sensitive bio-probes with their paramagnetic signals detected by electron paramagnetic resonance (EPR) spectrometry, however one consideration has always been biostability, as reduction to the hydroxylamine in vivo leads to slow loss of EPR signal [14] . If A-T cells are undergoing high levels of oxidative stress, bioreduction should be slowed and nitroxides might be expected to have beneficial impact, thus pointing the way towards a means of intervening in the progress of this currently untreatable disease.
Here we report the promising results of a study of three water soluble carboxy nitroxides on survival rates of A-T cells compared to normal cells when exposed to radiation; representing a model for understanding the impact of ROS damage on the A-T phenotype. The carboxy nitroxides all show a significant positive impact, raising A-T cell survival towards normal cell responses. The effect is much more significant than with vitamin E or Trolox (a water-soluble vitamin E analogue), studied using the same cell survival model.
MATERIALS AND METHODS

Materials
The chemical structures for the antioxidants used in this study are shown in Figure 1 .
CTEMPO (4-carboxy-2,2,6,6-tetramethylpiperidin-1-yloxyl, 2) and CPROXYL (3-carboxy-2,2,5,5-tetramethylpyrrolidin-1-yloxyl, 3); Tocopherol (2,5,7,8-tetramethyl-2-(4',8',12'trimethyltridecyl)-6-chromanol) (Vitamin E, 4) and Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, 5); were obtained from Sigma-Aldrich Pty Ltd, Australia and were used without further purification. Trypan Blue was obtained from Searle Diagnostics, UK and RPMI 1640 growth medium from Gibco-BRL. Foetal calf serum was also purchased from Gibco-BRL.
Synthesis of CTMIO and Derivatives
CTMIO, (5-Carboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl, 1)
CTMIO (5-carboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl, 1) was synthesised from 5-bromo-1,1,3,3-tetramethylisoindoline (see Scheme 1) via treatment with nbutyl lithium and carbon dioxide followed by oxidation to the nitroxide in 32% overall yield according to methods described previously [15, 16] . 
7.
Scheme 1
5-Carboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl amide (7)
The novel amide derivative of CTMIO, 5-carboxy-1,1,3,3tetramethylisoindolin-2-yloxyl amide (7) was made from the ethyl ester of CTMIO via exposure to NH 4 Cl and base. Thus CTMIO (1) (100 mg, 0.43 mmol) was refluxed in ethanol (3 mL) for 24 hours in the presence of catalytic amount of conc. H 2 SO 4 . The pH was raised with saturated NaHCO 3 (10 mL) and extracted with dichloromethane (3 x 30mL). Removal of the solvent yielded a yellow solid which was recrystallised from H 2 O/EtOH to give yellow needle-like crystals (83 mg, 74%) of the ethyl ester of CTMIO. This material (262 mg, 1.0 mmol) was dissolved in methanol/H 2 O (3mL/2mL), and NH 4 Cl (160 mg, 3 equiv.) and triethylamine (1.5 g) were added. The mixture was refluxed for 72 hours and extracted into dichloromethane (3 x 15 mL). The organic layer was dried with Na 2 SO 4 , and the solvent removed in vacuo. Separation from the starting material by column chromatography (4:6 EtOAc/hexane), and evaporation of solvent in vacuo, gave a yellow solid. (120 mg, 52%) Mp: 166-168° C; ν max (KBr)/cm -1 : 3500-3200 (NH 2 ), 2976 and 2929 (aryl CH), 1665 (amide C=O), 1618 and 1578 (aryl CH), 1466 and 1360 (NO). +MS found M + 233.12918 (0.78ppm from calc. mass for C 13 H 17 N 2 O 2 ). 1 HNMR (in presence of phenylhydrazine): δ H 1.48 (12H, s, CH 3 ), 6.14 (2H, broad, NH 2 ), 7.37 (1H, d, 7-H), 7.67 (1H, d, 4-H), 7.86 (1H, dd, 6-H). Peaks were present at 6.83 and 7.25 from phenylhydrazine and derivatives.
5-Carboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl acetoxymethyl ester (6)
CTMIO (1) (50 mg, 0.22 mmol) was dissolved in 3 mL DMF, and acetoxymethyl bromide (0.05 mL, 78 mg, 2.5 equiv.) and triethylamine (0.055 mL, 40 mg, 2 equiv.) were added. The mixture was refluxed under argon overnight, and then allowed to cool to room temperature. Once at room temperature, the reaction mixture was diluted with H 2 O (10 mL) and extracted with dichloromethane (3 x 15mL). The organic layer was dried with Na 2 SO 4 , and the solvent removed in vacuo. After column chromatography (CHCl 3 ), and evaporation of solvent in vacuo, a yellow solid was obtained. (46 mg, 71% The control cell line C3ABR and A-T cell line AT1ABR were obtained from a normal control and an A-T patient, respectively. Epstein-Barr virus was used to transform the cells to Lymphoblastoid Cell Lines (LCL) [17] . Cells were cultured in RPIM 1640 growth medium, containing 10% foetal calf serum (FCS) and incubated at 37°C in a 5% CO 2 /air atmosphere. The antioxidants investigated were first dissolved in 0.1 mL DMSO to prepare 0.1M stocks. This 0.1M stock solution was then diluted with the growth media to make 1 mL of 10 mM antioxidant stock. The cell lines of both A-T cells and standard cells were initially divided into four batches and diluted so the final concentrations were 100 µM. The first batch was not irradiated and not exposed to antioxidant, the second batch was irradiated in the absence of the antioxidant, the third batch was not irradiated, but was exposed to the antioxidant, and the last batch was irradiated in the presence of the antioxidant. All four aliquots were taken from the cultured medium and counted to ensure consistent numbers of cells were present in each aliquot used in the assay. Cells that were exposed to the antioxidant studied were exposed for at least six hours prior to the irradiation at the significantly lethal dose of 4 Gy.
Trypan Blue solution was used as a visualising media and it consisted of 0.4% w/w Trypan Blue in Hanks solution. The dye solution was allowed to settle at least 24 hours before use. A Trypan blue based visualisation assay using a bright-line hemacytometer and an optical microscope was used to determine the numbers of viable cells as described previously [18] .
To confirm the nitroxides have minimal toxicity under the conditions used in the experiment, cell growth was monitored in the presence of the nitroxides, but without exposure to irradiation. There was no apparent impact on growth rates and on numbers of dead cells, indicating no significant cytotoxicity with any of the compounds studied.
A cell count of the cell culture was conducted prior to all experiments, in order to measure the concentration of cells. Each experiment required dilution to obtain approx. 2 × 10 5 cells/mL. Appropriate amounts of the cell culture were transferred to culture tubes in order to attain approximately 2 × 10 5 cells/cm 3 after dilution to 5 mL. Antioxidant stock solution (50 µL of 10 mM) was added to the cell suspension such that the final concentration of the antioxidant in the tube after dilution to 5 mL was 100 µM.
The cell suspensions were irradiated at radiation doses varying from 0 Gy to 4 Gy at room temperature in a Gammacell 40 Exactor GC-40E, Ontario, Canada at a dose rate of 109.6 cGy/min. Results for the 4 Gy irradiation doses are shown. At lower doses similar trends were observed, but decreased lethality gave smaller differences between the A-T (AT1ABR) and control (C3ABR) cells. At doses higher than 4 Gy insufficient cells survive to obtain reliable data. After irradiation, the cell cultures were diluted to 5 mL, and incubated. To obtain cell counts, 0.1 mL of Trypan Blue solution and 0.5 mL of the well-mixed cell suspension were added to a vial. The mixture was allowed to sit for 2-3 minutes to enable the dyes to equilibrate. The cells were counted every 24 hours after irradiation up to a total time of 4 days.
All counts were conducted in triplicates, to ensure statistical validity of results. The cell suspensions were thoroughly mixed before any transfer, to ensure equal concentrations. Cell survivability was determined by the ratio of the number of living cells in irradiated samples compared to the number of cells surviving in samples not exposed to irradiation. Errors were calculated with 95% confidence intervals.
Chromosome Aberrations
Cells were treated with or without CTMIO (100 µM) for 4h and then irradiated with 1 Gy of γ-radiation under aerobic conditions. Colcemid (final concentration 0.1 µg/ml, Gibco BRL) was added immediately after irradiation, 1-2h before harvesting. The cells were treated for 15 min in 0.075M KCl, fixed in methanol-glacial acetic acid (3:1) and the fixed cells were spread on glass slides, air dried and stained with Giemsa (Gurr, BDH chemical). Fifty metaphases were analyzed for chromosomal aberrations for each sample.
RESULTS
FIGURE 2
As observed previously, exposure of A-T cells to radiation revealed that they were considerably more sensitive than normal control cells. Although both normal and A-T cells demonstrate reduced post-irradiation cell survival, A-T cells display significantly poorer growth in the first 24-48 hours, with few surviving past four days. This is shown in Figure 2 (Figure 2 , plot 1 -solid triangles). Significantly the protective effect towards A-T cells was considerably more marked than that observed when the control cells were similarly incubated with nitroxide prior to irradiation (Figure 2 , plot 1 -hollow triangles). Increasing the concentration of CTMIO to 200 µM did not further enhance survival (results not shown). Two other carboxylated nitroxides, CTEMPO (2) and CPROXYL (3), also significantly enhanced the survival of A-T cells post irradiation and again the protective effect was only minimal for control irradiated cells under the same conditions (Figure 2 , plots 2 -solid squares and 3 -solid circles).
which comprises a series of plots indicating the normal post-irradiation survival profile of healthy cells (Blank Control -solid diamonds) compared to A-T cells (Blank A-T -hollow diamonds). However, when the A-T cells were incubated in the presence of the antioxidant CTMIO (100 µM) prior to irradiation, survival was enhanced to a level intermediate between A-T and control
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In order to explore the universality of this effect on A-T cells, we employed two other antioxidants: alpha-Tocopherol (4) and Trolox (5) . Figure 3 (plot 1) shows the marginal differences in post-irradiation cell survival for both healthy cells and A-T cells in the presence of alpha-Tocopherol and Trolox. This low efficacy is replicated with the other nitroxides trialed (Figure 3, plot 2) . Interestingly, the primary amide nitroxide analogue (7) which is comparable in size and polarity to CTMIO, had no significant protective effect on A-T cells. Validation of the reproducibility of the assay is demonstrated by repeated separate cell survival assays each done in triplicate using CTMIO (Figure 3, plot 3) . (5-carboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl, 1) antioxidant on radiation-induced chromosomal aberrations We have previously shown that the number of radiation-induced chromosomal aberrations in A-T cells is approximately 3-fold higher than in irradiated control cells [17] . Since CTMIO partially corrected against radiation damage as determined by cell survival we also investigated whether this compound would reduce the number of radiation-induced chromosomal aberrations in A-T cells. When CTMIO was added to control cells prior to radiation the number of aberrations was approximately 1.00, comparable to that it unirradiated cells (Table 1 ). However, CTMIO reduced radiation-induced aberrations from 3.02 to an intermediate value of 1.72 in A-T cells a result compatible with the effect on cell survival described above.
Effect of CTMIO
DISCUSSION
The three carboxyl nitroxides studied all have a significant impact on the survival of the A-T cells. Whilst not reaching the levels of normal cells, the impact of these nitroxide antioxidants on A-T cell survival is greater than for the other antioxidant systems studied to date (notably vitamin E). The effect on survival is further supported by the capacity of the nitroxides to reduce radiation-induced chromosome aberrations in A-T cells. These results may represent an important first step towards the development of a treatment for A-T and other disorders characterized by oxidative stress.
The success of the carboxy nitroxides in protecting against cell death and induced chromosome aberrations lends support to the concept that A-T cells experience high levels of oxidative stress and lack the antioxidant defences of healthy cells [6] [7] [8] [9] [10] . Importantly the improvement of cell survival by the carboxy nitroxides is restricted to the A-T cells, with only minor changes detected in survival rates for the irradiated healthy cells. Nitroxides are recognised radioprotectors [19] , however, under the concentrations and conditions of these experiments, they are not offering much protection to healthy cells. With systems where the cellular antioxidant machinery may be flawed however, such as in the case of the A-T cells where oxidative stress is increased [6, 7] , the carboxy nitroxides clearly have a strong effect. Thus the preferential protection in A-T cells suggests that radiation damage to DNA is not the sole determinant of cell survival outcome, but rather a combination of DNA damage and an oxidative stress environment contribute to the sensitivity to radiation.
There have been comparisons of the relative bioactivity of various ring sized nitroxides which have shown some variation in the redox properties of five-membered versus six-membered ring systems [20] . These structural parameters do not appear to have much influence on the role that the nitroxides play in A-T cells. The three carboxy nitroxides examined all display similar impact on survival, despite representing much of the variation in chemical structures available in the nitroxide class of antioxidants. Of much greater influence appears to be the presence of the carboxy functional group itself. The primary amide analogue (7) would be expected to have comparable polarity and size to CTMIO, yet the impact of 7 on A-T cell survival is limited. Equally the lack of efficacy of 7 indicates that under these conditions there cannot be significant in situ metabolic conversion of this compound by the A-T cells to generate the more potent CTMIO parent.
Metabolic conversion of active esters has been used as a means of delivering high levels of nitroxides behind cell membranes in order to enhance imaging applications [21] . In this context the rapid intracellular enzymatic hydrolysis of active ester moieties, such as that present in 6, converts the membrane-permeable, lipophilic ester to the less permeable carboxylate, thereby trapping the nitroxide inside the cell. This makes the results of the active ester 6, which displayed very limited influence on A-T cell survival rates, very notable. Either limited enzymatic conversion of this compound occurs with 6 in A-T cells, or the mode of action of the carboxy nitroxides occurs extracellularly and the polarity of the carboxylate is the prime consideration.
Notably vitamin E in this trial proved much less effective than the carboxy nitroxides, despite being a widely recognised antioxidant system. This lower efficacy may arise from the possibility that nitroxides can act as catalytic antioxidants by involving the oxammonium salt redox couple [22] . Vitamin E on the other hand prevents damage by ROS by acting as a hydrogen atom transfer agent. Without resupply of more vitamin E, or in the face of poor enzymatic recovery of the phenoxy radical, the antioxidant efficiency must decrease.
To gain insight into the importance of water solubility and carboxylate salt structure on the antioxidant effect, the water soluble vitamin E analogue Trolox was also investigated using this irradiated A-T cell survival model. As with treatment with vitamin E, the A-T cells exposed to Trolox again showed little change in survivability.
The irradiated A-T cell survival model described here provides a simple, but effective means to identify substances which may have an impact on this disease. It is important to realise that results in vivo may be markedly different. Significantly however we have also shown marked improvement in survival of Purkinje neuronal cell cultures from Atm deficient mouse models treated with CTMIO [7] where after 10 days, treated cells had 60% of wild-type survival, double that recorded in untreated Atm -/cultures. Furthermore, neuronal differentiation in these cultures was improved when treated with CTMIO and, most significantly, catalase activity and 4nitrotyrosination of proteins, which are indicators of oxidative stress in the cerebellum, were markedly decreased in 2 month old Atm deficient mice which had been fed CTMIO.
In combination, these results indicate that carboxy nitroxides give insight into the important role oxidative stress plays in the disease ataxia-telangiectasia and indicate that antioxidants may provide a means of intervening in the progress of this disease. (5-carboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl, 1) , Plot 1; CTEMPO (4-carboxy-2,2,6,6-tetramethylpiperindinyloxyl, 2), Plot 2; and CPROXYL (3-carboxy-2,2,5,5- tetramethyl-1-pyrolidinyloxyl, 3) , Plot 3 
Figure 2: The Impact on A-T cell survival of: CTMIO
. Each Plot shows untreated A-T cell survival as the bottom curve and treated/untreated normal cell as the top two curves. In each case A-T cells treated with nitroxide display enhanced viability.
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